 This research paper discusses the development of a robotic platform for the production of patient-specific induced pluripotent stem cells, iPSCs, for autologous retinal cell replacement. The platform was used to generate patient-specific iPSCs which were then differentiated into photoreceptors. These photoreceptors were compared to those produced by manual methods and found to be equivalent in terms of morphology and gene expression. The authors concluded that their robotic platform can produce high-quality iPSCs suitable for clinical applications.